An interventional study of mHELP@ICU in ICU Delirium, sponsored by National Taiwan University Hospital. Recruiting at 1 site in Taiwan. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-11-28.
Sponsored by National Taiwan University Hospital · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 17 studies in Delirium with a site in Taiwan — 5 open to participants now, 6 under way, none of them phase 3. Delirium · Taiwan.
Among the 17 studies in Delirium with a site in Taiwan, this one is the 2nd largest by planned enrollment of the 11 interventional ones that give a count, is one of 5 that started in 2023, is one of 9 with no phase, and was the 8th registered.
935 studies on the registry are indexed under Delirium; 188 are open to participants now.
Browse Delirium studies →5 of the 17 studies in Delirium with a site in Taiwan are open now. Recruiting first, the newest first:
National Taiwan University Hospital · Sites in Taiwan
Ages 18+
Chang Gung Memorial Hospital · Sites in Taiwan
Ages 35–85 · Healthy volunteers
Tri-Service General Hospital · Sites in Taiwan
Ages 20–65 · Healthy volunteers
Taipei Medical University · Sites in Taiwan
Ages 18+ · Healthy volunteers
A study can be open while its sites in Taiwan have not opened yet or have stopped. Only those recruiting at a site in Taiwan →
Of the 124 Delirium studies recruiting now, 96 (77%) set no upper age limit and 8 (6%) stop at 75 or younger; 8 take children under 18; 14 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
17 studies; the count open now beside each. This study's row is marked.
First in 2008; this study’s year is marked. 5 started in 2023.
This study's planned enrollment of 266 is above the median of 111 across 551 interventional studies indexed under Delirium.
Median enrollment 100 across the 11 interventional studies, 328 across the 6 observational. Of the 10 that completed or were terminated, 2 (20%) have results posted.
This tab as a report to print or save as PDF → With an account.
1 of 17 have an industry lead sponsor. The 9 most frequent:
National Taiwan University Hospital is the lead sponsor of 2,617 studies on the registry; 575 are open to participants now.
Of its 11 completed or terminated interventional studies of FDA-regulated products, 2 (18%) have results posted.
National Taiwan University Hospital has 5 studies filed under Delirium — fewer than ten, so there is no comparison to draw.
1 of the studies in Delirium with a site in Taiwan that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06854497Chiayi Christian HospitalThe Impact of Non-motor Symptom on the Outcome of Stroke Subjects | 2026-12-31 |
Add it to your calendar (.ics) → With an account.
Among the 17 studies in Delirium with a site in Taiwan, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
Delirium, a form of acute brain dysfunction, occurs in up to 81% of patients receiving mechanical ventilation in the intensive care unit (ICU). Delirium occurring in the ICU is associated with increased functional dependency, cognitive impairment, longer length of hospital stay, and mortality. This study aim to develop a nursing-driven ICU delirium intervention to reduce incidence of delirium, increase the delirium-and coma-free days (DCFDs), and improve ICU patients' function, cognition, and mortality outcomes 3 months following their ICU admission. The "modified Hospital Elder life Program at the ICU (mHELP@ICU)" will be provided to ensure critically ill patients are cognitively engaged, physically active, and nutritionally well-fed.
This three-year study is divided into two phases. The first phase aims to ensure the accuracy of delirium assessment using the Intensive Care Delirium Screening Checklist (ICDSC) by ICU nurses of three participating ICUs. The ICDSC records assessed by ICU nurses will be abstracted from medical records and compared with a gold standard ICDSC evaluation by a well-trained, independent assessor. Cohen's kappa will be reported to represent the consistency of the ICDSC assessment between delirium data from medical records and the independent assessor. When the Cohen's kappa is less than 0.8, a 3-month bedside teaching and real-time feedback education program will be implemented at three ICU units to improve the accuracy of ICDSC assessment by ICU nurses. The second phase will be a clinical trial using a stepped-wedge cluster randomized controlled trial design. Adult (18 years and older) critically ill patients receiving mechanical ventilation will be consecutively enrolled from three mix-medical ICUs at a studied medical center. Estimated 266 participants will be cluster-randomized into the intervention and control groups. Participants in the intervention group will receive a 14-day mHELP@ICU, provided by a trained mHELP nurse, while the participants who received the usual care will serve as controls. Effects of mHELP@ICU will be evaluated using the daily delirium and coma data (max 14 days, or until death or ICU discharge) retrieved from the medical records, along with the participants' mortality, cognitive, and functional outcomes, which a blinded outcome assessor will assess at 48 hours, 14 days, 30 days, and 90 days after ICU admission.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria of the second phase
Participants will receive cognitive engagement twice daily, have physical activity once daily, and be monitored for their feeding. The intervention will be administered for 14 days or until hospital discharge or death.
Behavioral: mHELP@ICU
Participants in the control group will receive the usual care.
The 14-day mHELP@ICU consists of the following three components: 1. Cognitive engagement twice daily: Participants will receive orienting communication, plus one of the following training on attention, memory, or function execution. 2. Physical activity once daily: Participants will receive a passive range of motion(ROM) and/or anti-gravity ROM exercise if tolerated. 3. Feeding monitor daily: The exact feeding data will be abstracted from medical records.
Incidence of ICU delirium
Delirium (yes/no) using ICDSC will be abstracted from medical records.
Time frame: Admitted to ICU for 14 days
ICU delirium days
Delirium (yes/no) using ICDSC will be abstracted from medical records.
Time frame: Admitted to ICU for 14 days
Incidence of ICU coma
Coma (yes/no) defined by RASS score of -4 or -5 will be abstracted from medical records.
Time frame: Admitted to ICU for 14 days
ICU coma days
Coma (yes/no) defined by RASS score of -4 or -5 will be abstracted from medical records.
Time frame: Admitted to ICU for 14 days
Days of delirium- and coma-free days (DCFDs)
DCFDs (yes/no) are defined as the number of days during the study period during which the patient was alive without delirium or coma associated with any cause and obtained.
Time frame: Admitted to ICU for 14 days
Mortality
Data will be obtained from medical records or participants' families.
Time frame: Admitted to ICU for 90 days
Length of hospital stay
Data will be obtained from medical records.
Time frame: At hospital discharge
Medical Research Council (MRC) score
Participants' muscle strength will be evaluated using the medical research council scale (MRC). Score range from 0 to 60; a higher score indicates better muscle strength.
Time frame: At baseline (ICU admission); post-ICU 48 hours; day 30 and day 90 since ICU admission.
Functional Status Score for the Intensive Care Unit (FSS-ICU)
Participants' functional status will be evaluated using the FSS-ICU. Score range from 0 to 35, a higher score indicates better functional status.
Time frame: At baseline (ICU admission); post-ICU 48 hours; day 30 and day 90 since ICU admission.
30-second sit-to-stand test
Participants will be asked for sit-to-stand repeatedly for 30 seconds.
Time frame: Post-ICU 48 hours; day 30 and day 90 since ICU admission.
Barthel index for activities of daily living (ADL)
Measured by ADL in score, range from 0-100 score, higher score indicated health condition
Time frame: At baseline (ICU admission); post-ICU 48 hours; day 30 and day 90 since ICU admission.
Montreal Cognitive Assessment (MoCA)
Participants' cognitive function will be evaluated using th MoCA. Score range from 0-30 score, higher than 23.5 scores indicates normal cognitive.
Time frame: Post-ICU 48 hours; day 30 and day 90 since ICU admission.
Color Trails Test (CTT)
Participants' visual attention and effortful executive processing abilities will be evaluated using the CTT; the time taken to complete each part of the CTT is recorded in seconds and is compared to normative data.
Time frame: Post-ICU 48 hours; day 30 and day 90 since ICU admission.
Accuracy rate of ICDSC data (yes/no)
The ICDSC records assessed by ICU nurses will be abstracted from medical records and compared with a gold standard ICDSC evaluation by a well-trained, independent assessor.
Time frame: Randomly select four days per week to verify the accuracy of ICDSC data during the first three months of the study.
Started Sep 2023 (actual). Primary completion is estimated for Jul 2026, 34 months after the start.
Of 219 non-industry interventional studies with no phase under Delirium, half reached primary completion within 26 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 45. This study's planned 34 months is above that.
Counting every sponsor, half of 222 studies reached it within 26 months; a quarter within 12 and three quarters within 45.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
National Taiwan University Hospital →